These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37396335)

  • 41.
    Pêgo B; Martinusso CA; Bernardazzi C; Ribeiro BE; de Araujo Cunha AF; de Souza Mesquita J; Nanini HF; Machado MP; Castelo-Branco MTL; Cavalcanti MG; de Souza HSP
    Front Immunol; 2019; 10():442. PubMed ID: 30936867
    [No Abstract]   [Full Text] [Related]  

  • 42. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii.
    Liesenfeld O; Kosek J; Remington JS; Suzuki Y
    J Exp Med; 1996 Aug; 184(2):597-607. PubMed ID: 8760813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MyD88 is crucial for the development of a protective CNS immune response to Toxoplasma gondii infection.
    Torres M; Guiton R; Lacroix-Lamandé S; Ryffel B; Leman S; Dimier-Poisson I
    J Neuroinflammation; 2013 Feb; 10():19. PubMed ID: 23374751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A live attenuated RHΔompdcΔuprt mutant of Toxoplasma gondii induces strong protective immunity against toxoplasmosis in mice and cats.
    Shen Y; Zheng B; Sun H; Wu S; Fan J; Ding J; Gao M; Kong Q; Lou D; Ding H; Zhuo X; Lu S
    Infect Dis Poverty; 2023 Jun; 12(1):60. PubMed ID: 37322556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genome-wide comparative analysis revealed significant transcriptome changes in mice after Toxoplasma gondii infection.
    Jia B; Lu H; Liu Q; Yin J; Jiang N; Chen Q
    Parasit Vectors; 2013 Jun; 6():161. PubMed ID: 23734932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The immune system utilizes two distinct effector mechanisms of T cells depending on two different life cycle stages of a single pathogen, Toxoplasma gondii, to control its cerebral infection.
    Suzuki Y
    Parasitol Int; 2020 Jun; 76():102030. PubMed ID: 31778800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The High Potency of Green Synthesized Copper Nanoparticles to Prevent the Toxoplasma gondii Infection in Mice.
    Albalawi AE; Alanazi AD; Alyousif MS; Sepahvand A; Ebrahimi K; Niazi M; Mahmoudvand H
    Acta Parasitol; 2021 Dec; 66(4):1472-1479. PubMed ID: 34050875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Histopathological and ultrastructural assessment of atovaquone-proguanil hydrochloride combination in chronic murine toxoplasmosis.
    Elmehankar MS; Elhenawy AA; Aboukamar WA; Elzoheiry MA; Nabih N
    Ultrastruct Pathol; 2021 Nov; 45(6):376-383. PubMed ID: 34595988
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    Zhang Y; Jiang N; Zhang T; Wang D; Feng Y; Sang X; Yang N; Chen Q
    Front Microbiol; 2018; 9():2967. PubMed ID: 30564216
    [No Abstract]   [Full Text] [Related]  

  • 50. Experimental infection with Toxoplasma gondii in broiler chickens (Gallus domesticus): seroconversion, tissue cyst distribution, and prophylaxis.
    Nedişan ME; Györke A; Ştefănuţ CL; Kalmár Z; Friss Z; Blaga R; Blaizot A; Toma-Naic A; Mircean V; Schares G; Djurković-Djaković O; Klun I; Villena I; Cozma V
    Parasitol Res; 2021 Feb; 120(2):593-603. PubMed ID: 33415386
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of iNOS inhibitor on IFN-gamma production and apoptosis of splenocytes in genetically different strains of mice infected with Toxoplasma gondii.
    Kang KM; Lee GS; Lee JH; Choi IW; Shin DW; Lee YH
    Korean J Parasitol; 2004 Dec; 42(4):175-83. PubMed ID: 15591835
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brazilian strains of Toxoplasma gondii are controlled by azithromycin and modulate cytokine production in human placental explants.
    Franco PS; Gois PSG; de Araújo TE; da Silva RJ; de Freitas Barbosa B; de Oliveira Gomes A; Ietta F; Dos Santos LA; Dos Santos MC; Mineo JR; Ferro EAV
    J Biomed Sci; 2019 Jan; 26(1):10. PubMed ID: 30665403
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activity of isoflavone biochanin A in chronic experimental toxoplasmosis: impact on inflammation.
    Aboukamar WA; Elhenawy AA; Elmehankar MS; Elzoheiry MA; El-Gamal R; Elabbasy LM; Hany H; Nabih N
    Parasitol Res; 2022 Aug; 121(8):2405-2414. PubMed ID: 35710847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii.
    Suzuki Y; Yang Q; Remington JS
    J Parasitol; 1995 Dec; 81(6):1032-4. PubMed ID: 8544050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A human origin type II strain of Toxoplasma gondii causing severe encephalitis in mice.
    Djurković-Djaković O; Klun I; Khan A; Nikolić A; Knezević-Usaj S; Bobić B; Sibley LD
    Microbes Infect; 2006 Jul; 8(8):2206-12. PubMed ID: 16797199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deficient humoral responses underlie susceptibility to Toxoplasma gondii in CD4-deficient mice.
    Johnson LL; Sayles PC
    Infect Immun; 2002 Jan; 70(1):185-91. PubMed ID: 11748181
    [TBL] [Abstract][Full Text] [Related]  

  • 57. C57BL/6 mice immunized with synthetic peptides from Toxoplasma gondii surface and microneme immunodominant antigens are able to decrease parasite burden in the brain tissues.
    Barros HLS; Santana SS; Pajuaba ACAM; da Silva Cardoso Barros P; Dos Reis de Carvalho F; de Paiva VF; Wilson Patriarca Mineo T; Mineo JR
    Acta Trop; 2019 Aug; 196():1-6. PubMed ID: 31059707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Host resistance and immune deviation in pigeon cytochrome c T-cell receptor transgenic mice infected with Toxoplasma gondii.
    Collazo CM; Miller C; Yap G; Hieny S; Caspar P; Schwartz RH; Sher A
    Infect Immun; 2000 May; 68(5):2713-9. PubMed ID: 10768964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of an in vivo model for Toxoplasma gondii infections in chickens and turkeys simulating natural routes of infection.
    Geuthner AC; Koethe M; Ludewig M; Pott S; Schares G; Maksimov P; Daugschies A; Bangoura B
    Vet Parasitol; 2019 Dec; 276():108956. PubMed ID: 31706235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transforming growth factor-beta inhibits interleukin-12-induced production of interferon-gamma by natural killer cells: a role for transforming growth factor-beta in the regulation of T cell-independent resistance to Toxoplasma gondii.
    Hunter CA; Bermudez L; Beernink H; Waegell W; Remington JS
    Eur J Immunol; 1995 Apr; 25(4):994-1000. PubMed ID: 7737303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.